@SEC_Enforcement watch $MNKD for possible #REAL_TIME stock pumper manipulation. @US_FDA#FDA Office of Prescription Drug Promotion watch $mnkd social media for false and misleading claims denying risks and dangers of Black Box afrezza. Thank You.
$mnkd Wk ending 4/5. Scripts NRx 247 RRx 335. Do or die year for 28 year old company with only 1 drug approved 5 yrs ago. Afrezza not making required money. Weak financials.
@EtodayTtim Means nothing. $MNKD represents 0% of their holdings. Blackrock has holdings in every stock. It's also a major short player. Mnkd is running on empty.
$arna APD371 Not a Big Deal. Testing limited to crohn's stomach pain. Many exclusions on subjects. Trouble recruiting. N=20. Long hx of cb2 fails.
#pharma#stocks#biotechworld#oprah#drphil $AGN $nktr
$ARNA $CELG In ozanimod's phase 2 trial, the "partial" Mayo score results are available in the supplementary material Figure S4. At week 12, results are very similar to etrasimod - a 1-point difference against placebo. Also highly statistically significant.
Here we go again… $ARNA retail investor cult — still clinging to company from Belviq days — has been sending letters to investors/analysts, making wildly promotional and irresponsible claims about Arena. Unfortunate, right ahead of etrasimod data readout.
Does $arna mgmt really standstill as peeps afflilated with a music blog and other retail to send letters with outrageous pumps, pr promotions to WS analysts, funds, BP? LOL